Quick Answer
Drugs Made In America Acquisition Corp. reported Total Assets of $550.8 thousand for fiscal year 2024.
Drugs Made In America Acquisition Corp. — Key Financials by Year
| Metric | 2024 |
|---|---|
| Total Assets | $550.8K |
| Stockholders Equity | -$244.8K |
| Shares Outstanding | 9.86M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | $2.18M | +1607.3% | -4.5% |
| Total Assets | September 30, 2025 | $237.63M | — | +1.0% |
| Stockholders Equity | September 30, 2025 | -$7.33M | -4345.3% | -2.5% |
| Operating Income | September 30, 2025 | -$263.7K | -82.0% | -99.9% |
| Shares Outstanding | September 30, 2025 | 10.52M | — | +0.0% |
- Drugs Made In America Acquisition Corp. reported Total Assets of $550.8 thousand for fiscal year 2024.
- Drugs Made In America Acquisition Corp. reported Stockholders Equity of -$244.8 thousand for fiscal year 2024.
- Drugs Made In America Acquisition Corp. reported Shares Outstanding of 9.86 million shares for fiscal year 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: